Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base

No abstract is available for this paper.

• Publication year

  2006

• Venue

  British medical journal

• Publication date

  2006-06-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/BMJ.332.7556.1512PMID 16793832PMCID PMC1482353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer

  2006cited by this paper
• Improving surveillance for Barrett's oesophagus

  2006cited by this paper
• Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.

  2004cited by this paper

• Epidemiology of Barrett Esophagus and Risk Factors for Progression

  2019cites this paper
• Whole Genome Methylation Analysis of Nondysplastic Barrett sses to Invasive Cancer Esophagus that Progre

  2019cites this paper
• Oesophageal cancer

  2018cites this paper
• Timing and Protocols of Clinical and Endoscopic Surveillance of Barrett’s Esophagus

  2018cites this paper
• Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer

  2018cites this paper
• How to get the most out of costly Barrett's oesophagus surveillance.

  2018cites this paper
• Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.

  2017cites this paper
• Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease.

  2017cites this paper
• Polymorphisms Near TBX 5 and GDF 7 Are Associated With Increased Risk for Barrett ’ s

  2017influential citation
• Priority Setting in Barrett ’ s Oesophagus and Gastroesophageal Reflux Disease

  2017cites this paper
• Whole genome methylation analysis of non-dysplastic Barretts oesophagus that progresses to invasive cancer

  2017cites this paper
• Methodological considerations for surveillance in GI practice.

  2016cites this paper
• ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus

  2016cites this paper
• Novel epigenetic biomarkers for the Barrett's-adenocarcinoma sequence in oesophageal cancer

  2016cites this paper
• Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

  2016cites this paper
• Does Pre-Operative EUS Staging Have Influence on the 5 Year Survival Rate of Esophageal Cancer?

  2016cites this paper
• Progression of Barrett’s esophagus toward esophageal adenocarcinoma: an overview

  2016cites this paper
• Management of Barrett esophagus: a practical guide for clinicians based on the BADCAT and BoB CAT recommendations.

  2015cites this paper
• Clinical Guideline : Diagnosis and Management of Barrett ' s Esophagus

  2015cites this paper
• BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia

  2015cites this paper
• Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus

  2015cites this paper
• Identification of Two Novel Genome-Wide Significant Single Nucleotide Polymorphisms, associated with Barrett’s Oesophagus, determined by further Replication of a Genome-Wide Association Study

  2015cites this paper
• p53 Immunohistochemistry as a biomarker of dysplasia and neoplastic progression in Barrett's oesophagus

  2015cites this paper
• Barrett's oesophagus: Evidence from the current meta-analyses.

  2014cites this paper
• Vibrational spectroscopy for cancer diagnostics

  2014cites this paper
• Controversies in Barrett esophagus.

  2014cites this paper
• The role of inflammation in cancer of the esophagus

  2014cites this paper
• The esophagitis to adenocarcinoma sequence; the role of inflammation.

  2014cites this paper
• Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study

  2014cites this paper
• Oesophageal carcinoma.

  2013cites this paper
• Current Australian practice in the diagnosis and management of Barrett's oesophagus

  2013cites this paper
• The incidence and pathogenesis of 'recurrent' Barrett's metaplasia following oesophagectomy (neo-Barrett's)

  2013cites this paper
• The future developments in upper GI cancer

  2012cites this paper
• Natural history of Barrett's esophagus.

  2012cites this paper
• Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus

  2012cites this paper
• Reflux and Barrett’s disease. Can we stop surveillance after 2011?

  2012cites this paper
• Barrett's esophagus surveillance: When, how often, does it work?

  2011cites this paper
• Oesophageal cancer

  2011cites this paper
• Inflammation and gastrointestinal cancers

  2011cites this paper
• New Strategies in Barrett's Esophagus: Integrating Clonal Evolutionary Theory with Clinical Management

  2011influential citation
• Acid reflux and oesophageal cancer.

  2011cites this paper
• Gastrointestinal cancer: current screening strategies.

  2011cites this paper
• Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.

  2011cites this paper
• Predictors of Progression in Barrett's Esophagus: Current Knowledge and Future Directions

  2010cites this paper
• Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

  2010cites this paper
• Evaluation of Raman probe for oesophageal cancer diagnostics.

  2010cites this paper
• 3. Barrett's Esophagus

  2010cites this paper
• Esófago de Barrett

  2010cites this paper
• Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.

  2009cites this paper
• Advances in GERD: Current Developments in the Management of Acid-Related GI Disorders.

  2009cites this paper
• Unveiling Glucose Abnormalities in Patients With Chronic Hepatitis C Infection

  2009cites this paper
• Barrett's oesophagus.

  2009cites this paper
• Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study

  2008cites this paper
• Aspirin, Nonsteroidal Anti-inflammatory Drugs, and the Risks of Cancers of the Esophagus

  2008influential citation
• Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial

  2008cites this paper
• Should patients with Barrett's oesophagus be kept under surveillance? The case for.

  2008cites this paper
• Quimioprevención en adenocarcinoma de esófago

  2007cites this paper
• [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].

  2007cites this paper
• Adenocarcinoma in Barrett Esophagus: Too Common, Too Fatal, and Still Too Badly Managed

  2007cites this paper
• Dilemmas in managing Barrett's oesophagus

  2006cites this paper
• Guidelines for the management of oesophageal and gastric cancer

  2002cites this paper
• University of Birmingham Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus

  year unknowncites this paper
• GUTJNL228254 1449..1472

  year unknowncites this paper
• Guidelines for the management of oesophageal and gastric cancer

  year unknowncites this paper
• Guidelines for the management of oesophageal and gastric cancer

  year unknowncites this paper
• Guidelines for the management of oesophageal and gastric cancer

  year unknowncites this paper
• Guidelines for the management of oesophageal and gastric cancer

  year unknowncites this paper
• Guidelines for the management of oesophageal and gastric cancer

  year unknowncites this paper
• Guidelines for the management of oesophageal and gastric cancer

  year unknowncites this paper